FDA Investigator Jessica L Burley
Jessica L Burley has conducted inspections on 37 sites in 1 countries as of 06 Apr 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
06 Apr 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jessica L Burley:
Adam M True,
Amanda S Zorn,
Ana E Morales,
Ana L Kewes,
Andrew A Leboeuf,
Anthony R Ronga,
Ashley L Reiber,
Audrey Dela Cruz,
Bradley J Maunder,
Brian D Nicholson,
Brian P Emanuel,
Brittany R Laymon,
Bruce H Mccullough,
Carlyn L Ray,
Carrie Ann Plucinski,
Charlie P Booker,
Chase S Baldwin,
Christina A Miller,
Christopher B Harding,
Christopher D Leach,
Clotia Cabbey Mensah,
Daniel B Arrecis,
Dariusz Galezowski,
Darrell E Luedtke,
Dawnna D Brown,
Debra D Devlieger,
Debra Lboyd Seale,
Donna K Speer,
Edwardstine J Reese,
Eric S Pittman,
Freed A Sharif,
Geraldine G Phipps,
Humera T Khan,
Insook Son,
James E Roberts,
James P Duggan,
James T Karpus,
James W Plucinski,
Jeanne J Chiu,
Jeanne M Morris,
Jennifer C Adams,
Jennifer C Johnson,
Jesse A Vazquez,
Jessica L Diliberti,
Jocelyn C Turner,
Joseph A Morkunas,
Joseph D Cooper,
Joshua M Adams,
Justin R Hays,
Karen Emasley Joseph,
Kevin L Torgerson,
Kevin T Gerrity,
Kristen E Szenderski,
Kujtim Sadiku,
Lana K Waselewski,
Larry F Hallberg,
Lauren A Crivellone,
LCDR Mark A Jimenez, RN,
Lee Terry Moore,
Leslie D Hintz,
Liliya V Bubiy,
Logan M Ebeling,
Margaret Torres Vazquez,
Maria Diaz,
Mark G Peterson,
Mark I Kaspar,
Matthew J Sienko,
Matthew R Buenconsejo,
Michael D Robinson,
Nicole J Clausen,
Nicole S Williams,
Norman L Brown,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Patrick E Gainer,
Paula P Demichael,
Rafael Padilla,
Renee L Anderson,
Rosemary Wood Sexton,
Roshni J Patel,
Russell K Riley,
Ruth Smith,
Samuel W Labinjo,
Shana L Williams,
Stefen D Mcmillan,
Sullan,
Susan W Ciani,
Tara A Marshall,
Tara C Alcazar,
Tara M Carolfi,
Tarsha Oliver,
Theresa C Klaman,
Thomas W Nojek,
Thunder N Dunkijacobs,
Todd M Stankewicz,
Uruaku A Obasi,
William D Sherman,
William G Nelson,
William R Weissinger
Jessica L Burley's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2011 | EIR | Nutripack LLC - EIR, 2011-02-10 |
February, 2011 | FDA 483 | Nutripack LLC - Form 483, 2011-02-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more